Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 80
Filter
1.
Neurol Med Chir (Tokyo) ; 60(6): 277-285, 2020 Jun 15.
Article in English | MEDLINE | ID: mdl-32404575

ABSTRACT

Most cases of optic hypothalamic pilocytic astrocytoma (OHPA) develop during childhood, so few cases of histologically verified OHPA have been described in adolescents and young adults (AYA). To elucidate the clinical features of OHPA with histological verification in AYA, we reviewed the clinical and radiological finding of OHPA treated at our institute from January 1997 and July 2017. AYA are aged between 15 and 39 years. The clinical courses of 11 AYA patients with optic hypothalamic glioma (OHG) without neurofibromatosis type 1 were retrospectively reviewed. About six patients were diagnosed in childhood and followed up after 15 years of age, and five patients developed OHPA during AYA. Histological diagnosis, verified at initial presentation or recurrence, was pilocytic astrocytoma in 10 and pilomyxoid astrocytoma in one. After initial treatment including debulking surgery and/or chemotherapy, tumor progression occurred 16 times in seven patients as cyst formation, tumor growth, and intratumoral hemorrhage. Five of 10 patients suffered deterioration of visual function during AYA. One of 10 cases had endocrinopathies requiring hormone replacement at last follow-up examination. In conclusion, histological diagnoses of OHG before and in AYA were pilocytic astrocytoma or pilomyxoid astrocytoma. Both pediatric and AYA-onset OHPA demonstrate high incidences of tumor progression and visual dysfunctions in AYA, so that long-term follow up is essential after the completion of treatment for pediatric and AYA-onset OHPA. The optimal timing of debulking surgery and radiation therapy should be established to achieve the long-term tumor control and to preserve the visual function.


Subject(s)
Astrocytoma/pathology , Hypothalamic Neoplasms/pathology , Adolescent , Adult , Age Factors , Astrocytoma/diagnostic imaging , Astrocytoma/therapy , Disease Progression , Female , Humans , Hypothalamic Neoplasms/diagnostic imaging , Hypothalamic Neoplasms/therapy , Male , Neuroradiography , Retrospective Studies , Young Adult
4.
World Neurosurg ; 128: 527-531, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31048046

ABSTRACT

BACKGROUND: Diffuse midline glioma H3 K27M mutant is a new tumor entity described in the revised 2016 World Health Organization classification. It is most frequently observed in children and develops in midline structures, including the brainstem, thalamus, and spine. We describe a rare diffuse midline glioma with an H3 K27M mutation arising in the hypothalamus of an adult. CASE DESCRIPTION: A 27-year-old woman was admitted to our department complaining of amenorrhea, polydipsia, and diuresis for the previous 3 months, and headache and lethargy for approximately 10 days. Computed tomography scan showed an oval isodense solid mass extending from the pituitary toward the suprasellar cistern. A gadolinium-enhanced magnetic resonance imaging (MRI) showed a strongly heterogeneous enhanced solid lesion and nonenhanced cystic lesion. The patient underwent surgery and chemoradiotherapy with temozolomide. Histologic and immunohistochemical analyses revealed H3 K27M-mutant diffuse midline glioma. The patient underwent another resection for a recurrent tumor 5 months after the first surgery. Three months after the second operation, the patient relapsed, with MRI revealing spinal cord and meningeal metastases; she died shortly afterward. CONCLUSIONS: Diffuse midline glioma with an H3 K27M mutation occurring in the hypothalamus of an adult is rare but should be considered in differential diagnoses. Because histone H3 K27M mutations are associated with aggressive clinical behavior and poor prognosis, molecular analyses should be used to determine the clinical and histopathologic features of such tumors. This will contribute to developing targeted drugs and gene therapy going forward.


Subject(s)
Glioma/surgery , Hypothalamic Neoplasms/surgery , Adenoma/diagnosis , Adult , Amenorrhea/etiology , Diagnosis, Differential , Diuresis , Female , Glioma/complications , Glioma/diagnostic imaging , Glioma/genetics , Histones/genetics , Humans , Hypopituitarism/etiology , Hypothalamic Neoplasms/complications , Hypothalamic Neoplasms/diagnostic imaging , Hypothalamic Neoplasms/genetics , Pituitary Neoplasms/diagnosis , Polydipsia/etiology , Sella Turcica/diagnostic imaging
6.
World Neurosurg ; 126: 631-637, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30877002

ABSTRACT

BACKGROUND: Endovascular mechanical thrombectomy (MT) performed with stent retriever devices have proven efficacious in the treatment of adult patients with acute cerebral ischemia resulting from large-vessel occlusion. Recently, reports describing the use of MT in pediatric large-vessel occlusion have increased. However, these case reports are generally limited to older children and teenagers. CASE DESCRIPTION: We report the use of a Solitaire (Medtronic, Minneapolis, Minnesota, USA) stent retriever for thrombectomy and revascularization of the right middle cerebral artery) in a 6-month-old patient. CONCLUSIONS: To our knowledge, this is the youngest patient reported to be treated with MT using a stent retriever. This case adds to the growing literature that supports the use of MT as a stroke intervention in pediatric patients.


Subject(s)
Arterial Occlusive Diseases/surgery , Carotid Artery, Internal/surgery , Endovascular Procedures/instrumentation , Mechanical Thrombolysis/instrumentation , Postoperative Complications/surgery , Aneurysm, False/diagnostic imaging , Aneurysm, False/therapy , Astrocytoma/diagnostic imaging , Astrocytoma/surgery , Carotid Artery, Internal/pathology , Cerebral Angiography , Cerebral Hemorrhage/etiology , Embolization, Therapeutic , Endovascular Procedures/methods , Humans , Hypothalamic Neoplasms/diagnostic imaging , Hypothalamic Neoplasms/surgery , Infant , Magnetic Resonance Imaging , Male , Mechanical Thrombolysis/methods , Neuroimaging , Postoperative Complications/etiology , Postoperative Complications/pathology , Seizures/etiology
7.
Childs Nerv Syst ; 35(1): 63-72, 2019 01.
Article in English | MEDLINE | ID: mdl-30078056

ABSTRACT

PURPOSE: Optic pathway gliomas represent 5% of pediatric brain tumors and are typically low-grade lesions. Because of their unpredictable clinical course, adequate treatment approaches have been controversial, involving surveillance, surgery, chemotherapy, and radiotherapy. In this study, we use volumetric imaging to compare evolution of optic chiasmatic-hypothalamic gliomas (OCHG) treated with and without chemotherapy, analyzing tumor volume variation during the overall period. METHODS: A total of 45 brain MRI were retrospectively analyzed for 14 patients with OCHG. Volumetric assessment of the lesions was performed by a neuroradiologist, using software DISPLAY. OCHG patients were allocated into two groups: group 1 (n = 8) who underwent chemotherapy and group 2 (n = 6) who did not receive chemotherapy. Outcome analysis was performed comparing tumor volume evolution of these two groups. RESULTS: The results showed a reduction of 4.4% of the volume of the lesions for group 1 after the end of chemotherapy, with an increase of 5.3% in volume in the late follow-up examination. For group 2, we found a slight reduction (5%) of the overall volume of the lesions, both with no statistical significance (p > 0.05). CONCLUSIONS: From the limited series analyzed in this study, no significant differences were observed in relation to the volume change of lesions treated or not treated with chemotherapy. Larger prospective clinical trials are needed to better evaluate the effect of chemotherapy and radiological response of OCHG.


Subject(s)
Antineoplastic Agents/therapeutic use , Glioma/diagnostic imaging , Glioma/drug therapy , Hypothalamic Neoplasms/diagnostic imaging , Hypothalamic Neoplasms/drug therapy , Magnetic Resonance Imaging/methods , Optic Chiasm , Optic Nerve Neoplasms/diagnostic imaging , Optic Nerve Neoplasms/drug therapy , Adolescent , Antineoplastic Agents, Phytogenic/therapeutic use , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Male , Monitoring, Physiologic , Neuroimaging/methods , Retrospective Studies , Treatment Outcome , Vinblastine/therapeutic use
8.
Epilepsia ; 59(12): 2284-2295, 2018 12.
Article in English | MEDLINE | ID: mdl-30374947

ABSTRACT

OBJECTIVE: The purpose of this study is to investigate the outcomes of epilepsy surgery targeting the subcentimeter-sized resting state functional magnetic resonance imaging (rs-fMRI) epileptogenic onset zone (EZ) in hypothalamic hamartoma (HH). METHODS: Fifty-one children with HH-related intractable epilepsy received anatomical MRI-guided stereotactic laser ablation (SLA) procedures. Fifteen of these children were control subjects (CS) not guided by rs-fMRI. Thirty-six had been preoperatively guided by rs-fMRI (RS) to determine EZs, which were subsequently targeted by SLA. The primary outcome measure for the study was a predetermined goal of 30% reduction in seizure frequency and improvement in class I Engel outcomes 1 year postoperatively. Quantitative and qualitative volumetric analyses of total HH and ablated tissue were also assessed. RESULTS: In the RS group, the EZ target within the HH was ablated with high accuracy (>87.5% of target ablated in 83% of subjects). There was no difference between the groups in percentage of ablated hamartoma volume (P = 0.137). Overall seizure reduction was higher in the rs-fMRI group: 85% RS versus 49% CS (P = 0.0006, adjusted). The Engel Epilepsy Surgery Outcome Scale demonstrated significant differences in those with freedom from disabling seizures (class I), 92% RS versus 47% CS, a 45% improvement (P = 0.001). Compared to prior studies, there was improvement in class I outcomes (92% vs 76%-81%). No postoperative morbidity or mortality occurred. SIGNIFICANCE: For the first time, surgical SLA targeting of subcentimeter-sized EZs, located by rs-fMRI, guided surgery for intractable epilepsy. Our outcomes demonstrated the highest seizure freedom rate without surgical complications and are a significant improvement over prior reports. The approach improved freedom from seizures by 45% compared to conventional ablation, regardless of hamartoma size or anatomical classification. This technique showed the same or reduced morbidity (0%) compared to recent non-rs-fMRI-guided SLA studies with as high as 20% permanent significant morbidity.


Subject(s)
Drug Resistant Epilepsy/diagnostic imaging , Drug Resistant Epilepsy/surgery , Hamartoma/surgery , Hypothalamic Diseases/surgery , Hypothalamic Neoplasms/surgery , Neurosurgical Procedures/methods , Adolescent , Child , Child, Preschool , Drug Resistant Epilepsy/etiology , Female , Hamartoma/complications , Hamartoma/diagnostic imaging , Humans , Hypothalamic Diseases/complications , Hypothalamic Diseases/diagnostic imaging , Hypothalamic Neoplasms/complications , Hypothalamic Neoplasms/diagnostic imaging , Infant , Magnetic Resonance Imaging , Male , Postoperative Complications/epidemiology , Reproducibility of Results , Treatment Outcome , Young Adult
9.
P R Health Sci J ; 37(3): 174-176, 2018 09.
Article in English | MEDLINE | ID: mdl-30188563

ABSTRACT

OBJECTIVE: A rare, low-grade tumor found in the hypothalamus and anterior third ventricle, a chordoid glioma presents a challenge to neurosurgeons: Its successful resection is complicated by its inconvenient location. CASE DESCRIPTION: A 42-year-old male patient presented with a 1-year history of major depressive disorder, with psychotic features associated with generalized tonic-clonic seizures. Brain magnetic resonance imaging (MRI) with contrast revealed a suprasellar mass extending into the third ventricle To resect the lesion, an interhemispheric transcallosal transventricular subfornical approach was used. Pathology revealed a chordoid glioma. The patient had a complicated post-operative period that included the development of neurogenic diabetes insipidus, followed by intractable hyponatremia and death (caused by malignant brain edema). CONCLUSION: A chordoid glioma is a rare neoplasm that, in 2000, was incorporated into the World Health Organization (WHO) classification of central nervous system tumors. Due to its rarity, it is seldom considered in the differential diagnosis of suprasellar masses. Moreover, its unusual presentation and difficult location present a challenge for surgical and medical management.


Subject(s)
Glioma/complications , Hypothalamic Neoplasms/complications , Psychotic Disorders/etiology , Adult , Glioma/diagnostic imaging , Glioma/surgery , Humans , Hypothalamic Neoplasms/diagnostic imaging , Hypothalamic Neoplasms/surgery , Male
10.
J Craniofac Surg ; 29(5): e499-e502, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29570532

ABSTRACT

Optic pathway hypothalamic gliomas are intrinsic low-grade gliomas involving the optic nerve, chiasm, optic tract, and hypothalamus. The rarity of these tumors and their unpredictable course make assessment and standardization of treatment modalities difficult. Tumor debulking via various transcranial approaches was considered to be effective at controlling tumor growth, but with high rates of severe surgery-related complications. In the present case, endoscopic transsphenoidal surgery was initiated to debulk the exophytic chiasmatic/hypothalamic glioma with good preservation of hypothalamic and endocrine functions. The authors suggest transsphenoidal surgery with tumor debulking could be an effective and safe treatment for patients with chiasmatic/hypothalamic gliomas.


Subject(s)
Astrocytoma/surgery , Endoscopy , Hypothalamic Neoplasms/surgery , Optic Chiasm/surgery , Optic Nerve Neoplasms/surgery , Adult , Astrocytoma/diagnostic imaging , Astrocytoma/pathology , Humans , Hypothalamic Neoplasms/diagnostic imaging , Hypothalamic Neoplasms/pathology , Male , Optic Chiasm/diagnostic imaging , Optic Chiasm/pathology , Optic Nerve Neoplasms/diagnostic imaging , Optic Nerve Neoplasms/pathology
11.
Orbit ; 37(3): 208-211, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29053048

ABSTRACT

Neurofibromatosis type 1 (NF1) is an inherited disorder often associated with optic nerve gliomas, low-grade brain tumors, and readily visible signs. Though these features are frequently emphasized, the psychosocial and emotional morbidities are often overlooked. We present a patient with depressive disorder resulting in suicide in a patient with NF1.


Subject(s)
Astrocytoma/pathology , Depressive Disorder/pathology , Hypothalamic Neoplasms/pathology , Neurofibromatosis 1/pathology , Optic Nerve Neoplasms/pathology , Suicide , Adolescent , Astrocytoma/diagnostic imaging , Depressive Disorder/diagnosis , Female , Humans , Hypothalamic Neoplasms/diagnostic imaging , Magnetic Resonance Imaging , Neurofibromatosis 1/diagnostic imaging , Optic Nerve Neoplasms/diagnostic imaging
12.
Article in Russian | MEDLINE | ID: mdl-29076472

ABSTRACT

Diencephalic cachexia (DС) is progressive weight loss despite a normal caloric intake and a satisfactory state of health, which is caused by hypothalamic lesions. This is a rare (about 100 cases were reported) and potentially fatal disorder of unknown pathogenesis. At present, there is no effective pharmacological therapy for the disorder. Cachexia may regress only if the tumor reduces in size, therefore the timely diagnosis and treatment are of vital importance for the patient. DС is typical of early childhood, and only a few cases have been reported in adults. We present a rare case of DС in a 24-year-old female with papillary craniopharyngioma.


Subject(s)
Cachexia , Craniopharyngioma , Hypothalamic Neoplasms , Pituitary Neoplasms , Adult , Cachexia/blood , Cachexia/diagnostic imaging , Cachexia/physiopathology , Cachexia/surgery , Craniopharyngioma/blood , Craniopharyngioma/diagnosis , Craniopharyngioma/physiopathology , Craniopharyngioma/surgery , Female , Humans , Hypothalamic Neoplasms/blood , Hypothalamic Neoplasms/diagnostic imaging , Hypothalamic Neoplasms/physiopathology , Hypothalamic Neoplasms/surgery , Pituitary Neoplasms/blood , Pituitary Neoplasms/diagnostic imaging , Pituitary Neoplasms/physiopathology , Pituitary Neoplasms/surgery
14.
Cortex ; 89: 98-110, 2017 04.
Article in English | MEDLINE | ID: mdl-28259055

ABSTRACT

Patients with hypothalamic involvement of a sellar/parasellar tumor often suffer from cognitive and social-emotional deficits that a lesion in the hypothalamus cannot fully explain. It is conceivable that these deficits are partly due to distal changes in hypothalamic networks, evolving secondary to a focal lesion. Focusing on childhood-onset craniopharyngioma patients, we aimed at investigating the impact of hypothalamic lesions on gray and white matter areas densely connected to the hypothalamus, and to relate structural changes to neuropsychological deficits frequently observed in patients. We performed a voxel-based morphometric analysis based on data of 11 childhood-onset craniopharyngioma patients with hypothalamic tumor involvement, and 18 healthy controls (median age: 17.2 and 17.4 yrs.). Whole-brain analyses were used to test for volumetric differences between the groups (T-tests) and subsequent regression analyses were used to correlate neuropsychological performance with gray and white matter volumes within the patient group. Patients compared to controls had significantly reduced gray matter volumes in areas of the anterior and posterior limbic subsystems which are densely connected with the hypothalamus. In addition, a reduction in white matter volumes was observed in tracts connecting the hypothalamus to other limbic areas. Worse long-term memory retrieval was correlated with smaller gray matter volumes in the posterior cingulate cortex. Our data provide the first evidence that hypothalamic tumor involvement impacts gray and white matter volumes in limbic areas, outside the area of tumor growth. Notably, the functional range of the two limbic subsystems affected, strikingly parallels the two major domains of psychological complaints in patients i.e., deficits in episodic memory and in socio-emotional functioning. We suggest that focal hypothalamic lesions may trigger distal changes in connected brain areas, which then contribute to the impairments in cognitive, social and emotional performance often observable in patients, and not explicable by a hypothalamic lesion alone.


Subject(s)
Craniopharyngioma/diagnostic imaging , Frontal Lobe/diagnostic imaging , Gray Matter/diagnostic imaging , Hypothalamic Neoplasms/diagnostic imaging , Limbic System/diagnostic imaging , White Matter/diagnostic imaging , Adolescent , Adult , Child , Craniopharyngioma/pathology , Female , Frontal Lobe/pathology , Gray Matter/pathology , Humans , Hypothalamic Neoplasms/pathology , Limbic System/pathology , Male , Organ Size , White Matter/pathology , Young Adult
16.
J Neurosurg Pediatr ; 19(3): 319-324, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28009226

ABSTRACT

Brain tumors are the most common solid tumor in childhood, and astrocytomas account for the largest proportion of these tumors. Increasing sophistication in genetic testing has allowed for the detection of specific mutations within tumor subtypes that may represent targets for individualized tumor treatment. The mitogen-activating protein kinase (MAPK) pathway and, more specifically, BRAF mutations have been shown to be prevalent in pediatric pilocytic astrocytomas and may represent one such area to target. Herein, the authors describe 2 cases of inoperable, chemotherapy-resistant pediatric pilocytic astrocytomas with a documented response to trametinib, an MAPK pathway inhibitor. While these cases were not treated in the setting of a clinical trial, their data support further ongoing clinical trial investigation to evaluate the safety and efficacy of this agent in pediatric low-grade gliomas.


Subject(s)
Antineoplastic Agents/therapeutic use , Astrocytoma/diagnostic imaging , Disease Progression , Hypothalamic Neoplasms/diagnostic imaging , Optic Nerve Neoplasms/diagnostic imaging , Pyridones/therapeutic use , Pyrimidinones/therapeutic use , Astrocytoma/drug therapy , Child, Preschool , Female , Humans , Hypothalamic Neoplasms/drug therapy , Infant , Optic Nerve Neoplasms/drug therapy , Organ Size , Treatment Outcome
17.
Eur J Clin Nutr ; 70(12): 1451-1453, 2016 12.
Article in English | MEDLINE | ID: mdl-27507066

ABSTRACT

Severe obesity is a common consequence of hypothalamic region diseases and their treatment. Only two previous case reports have described hypothalamic lipomas in children with obesity. We described a case of an adult with severe obesity associated with hypothalamic lipoma attached to the third ventricle floor who underwent Roux-en-Y gastric bypass. He lost 38 and 59 kg at 6 and 12 months after surgery, respectively. Weight loss after bariatric surgery was as expected in this patient with severe obesity. At 6 and 12 months, brain magnetic resonance imaging (MRI) showed stability in lipoma's size.


Subject(s)
Gastric Bypass , Hypothalamic Neoplasms/complications , Lipoma/complications , Obesity, Morbid/surgery , Adult , Humans , Hypothalamic Neoplasms/diagnostic imaging , Lipoma/diagnostic imaging , Male , Weight Loss
18.
J Clin Neurosci ; 33: 217-220, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27450285

ABSTRACT

Pilomyxoid astrocytoma (PMA) is a rare, low-grade glioma that is recognised as a variant of pilocytic astrocytoma. There have been few reports on this pathologic entity presenting with spontaneous haemorrhage. In this study, we report a rare case of PMA in the hypothalamic/chiasmatic region presenting with intratumoural and intraventricular haemorrhage. An external ventricular drain was urgently inserted. A ventriculo-peritoneal shunt (VP) was undergone 4weeks thereafter. The patient received fractionated Gamma Knife radiosurgery in another hospital 3weeks after the VP shunt. Three months later, subtotal resection of the tumour was performed in our hospital via a pterional approach. The pathological diagnosis was PMA. Postoperatively, no adjuvant therapy was given, and the neurologic deficits were improved. However, the presentation of endocrine deficits remained. Notably, PMAs in the hypothalamic/chiasmatic region presenting with massive intratumoural and intraventricular haemorrhage may result in a severe condition and long-term impairment of endocrine function. Long-term follow-up is required to monitor the recurrence of the tumour and endocrinopathy.


Subject(s)
Astrocytoma/complications , Cerebral Ventricles/pathology , Hypothalamic Neoplasms/complications , Intracranial Hemorrhages/etiology , Adolescent , Astrocytoma/diagnostic imaging , Astrocytoma/surgery , Cerebral Ventricles/diagnostic imaging , Cerebral Ventricles/surgery , Drainage , Humans , Hypothalamic Neoplasms/diagnostic imaging , Hypothalamic Neoplasms/surgery , Intracranial Hemorrhages/diagnostic imaging , Intracranial Hemorrhages/surgery , Magnetic Resonance Imaging , Male , Radiosurgery , Tomography, X-Ray Computed , Treatment Outcome , Ventriculoperitoneal Shunt
19.
J Neurosurg Pediatr ; 18(4): 430-433, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27258590

ABSTRACT

The authors report a case of a child with hypothalamic-origin pilocytic astrocytoma and hydrocephalus, which was refractory to treatment with a ventriculoperitoneal shunt due to high CSF protein content. With parental education, the child's hydrocephalus was managed long-term in the community with a long-tunnelled external ventricular drain, which was maintained by his parents. To the authors' knowledge this is the first report of this management option as a long-term measure. No harm has come to the patient. The authors propose long-term, long-tunnelled external ventricular drain as a viable treatment option for such patients.


Subject(s)
Astrocytoma/complications , Cerebrospinal Fluid Shunts/methods , Hydrocephalus/complications , Hydrocephalus/surgery , Hypothalamic Neoplasms/complications , Palliative Care/methods , Astrocytoma/diagnostic imaging , Astrocytoma/drug therapy , Astrocytoma/pathology , Humans , Hydrocephalus/diagnostic imaging , Hypothalamic Neoplasms/diagnostic imaging , Hypothalamic Neoplasms/drug therapy , Hypothalamic Neoplasms/pathology , Infant , Male , Neoplasm Grading , Reoperation , Time Factors
20.
World Neurosurg ; 90: 707.e17-707.e21, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27004758

ABSTRACT

BACKGROUND: The co-occurrence of cerebral gliomas and cavernous angiomas is rarely encountered in clinical practice. All reported cases with such association have occurred within the brain with none involving the spinal cord. CASE DESCRIPTION: The authors report the case of a hypothalamic-optochiasmatic pilocytic astrocytoma coexisting with right occipital and sacral spinal cavernomas. This 30-year-old man had an 8-year history of chronic lower back pain. Spinal magnetic resonance imaging (MRI) demonstrated an 8.2-cm expansile multilobulated heterogeneously enhancing intradural mass within the sacral spinal canal, extending into the bilateral S1 and left S2 foramina. Brain MRI depicted a 2.9-cm lobulated heterogeneously enhancing sellar-suprasellar solid and cystic mass expanding the sella and displacing the infundibulum to the right, with a normal-appearing pituitary gland inside the sella, and an extensive supratentorial and infratentorial superficial hemosiderosis. L5-S4 laminectomy and pterional craniotomy were performed for the resection of these lesions. Histopathologic examination revealed a sacral spinal cavernoma and a suprasellar hypothalamic-optochiasmatic pilocytic astrocytoma. CONCLUSION: The coexistence of hypothalamic-optochiasmatic pilocytic astrocytoma and occipital and sacral spinal cavernomas has not been reported previously. Especially for radiologically atypical suprasellar lesions, hypothalamic-optochiasmatic glioma should be included in the differential diagnosis of masses that can expand the sella. Besides previously postulated hypotheses of viral-induced or angiogenic factor-induced glial growth, we hypothesize that neoplastic origins of hypothalamic-optochiasmatic glioma might be due to the irritative mechanisms resulting from the frequent bleeds occurring from the spinal or cranial cavernoma.


Subject(s)
Astrocytoma/diagnostic imaging , Brain Neoplasms/diagnostic imaging , Hemangioma, Cavernous, Central Nervous System/diagnostic imaging , Neoplasms, Multiple Primary/diagnostic imaging , Spinal Neoplasms/diagnostic imaging , Adult , Astrocytoma/surgery , Brain Neoplasms/surgery , Craniotomy/methods , Hemangioma, Cavernous, Central Nervous System/surgery , Humans , Hypothalamic Neoplasms/diagnostic imaging , Hypothalamic Neoplasms/surgery , Laminectomy/methods , Male , Neoplasms, Multiple Primary/surgery , Occipital Lobe/diagnostic imaging , Occipital Lobe/surgery , Spinal Neoplasms/surgery , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...